Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00259090 | Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer | completed | Phase 2 | 120 | AstraZenecaINDUSTRY | 1 | Aug 16, 2012 | clinicaltrials |
| NCT01003951 | Acupuncture for the Treatment of Chronic Lymphedema | completed | Phase 2 | 37 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 16, 2012 | clinicaltrials |
| NCT00943410 | Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer | completed | Phase 2 | 19 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | Aug 15, 2012 | clinicaltrials |
| NCT00006104 | Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 46 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 14, 2012 | clinicaltrials |
| NCT00429572 | Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT01149798 | A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer | completed | Phase 2 | 73 | Fudan UniversityOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00299286 | Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer(MAPLE) | completed | Phase 2 | 121 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 6, 2012 | clinicaltrials |
| NCT00002837 | High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00003099 | Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer | completed | Phase 2 | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00005980 | Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 18, 2012 | clinicaltrials |
| NCT00028873 | R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | completed | Phase 2 | 35 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 18, 2012 | clinicaltrials |
| NCT00066339 | Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy | completed | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00401427 | HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer | completed | Phase 2 | 50 | National Cancer Institute, NaplesOTHER | 0 | Jul 13, 2012 | clinicaltrials |
| NCT00788333 | Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer | completed | Phase 1 / Phase 2 | 40 | Bristol-Myers SquibbINDUSTRY | 5 | Jul 13, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT01611727 | Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients(Cisplatin) | completed | Phase 2 | 20 | Pomeranian Medical University SzczecinOTHER | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00008437 | MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer | completed | Phase 2 | — | InSightecINDUSTRY | 2 | Jul 2, 2012 | clinicaltrials |
| NCT00464516 | Preoperative Estetrol in Breast Cancer | completed | Phase 2 | 30 | Pantarhei BioscienceINDUSTRY | 1 | Jul 2, 2012 | clinicaltrials |
| NCT00445406 | Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 43 | Swiss Cancer InstituteOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00754351 | Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer | completed | Phase 2 | 48 | University Hospital of CreteOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00503750 | Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™) | completed | Phase 2 | 27 | Emory UniversityOTHER | 1 | Jun 25, 2012 | clinicaltrials |
| NCT01042938 | Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients | completed | Phase 2 | 35 | University of RochesterOTHER | 1 | Jun 25, 2012 | clinicaltrials |
| NCT00784849 | Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627) | completed | Phase 2 | 62 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00004172 | Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00004175 | Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004182 | Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00006225 | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00135018 | Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer | completed | Phase 2 | — | Organisation for Oncology and Translational ResearchOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00004046 | Chemotherapy in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00286819 | Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer | completed | Phase 2 | 50 | Central European Cooperative Oncology GroupOTHER | 4 | May 16, 2012 | clinicaltrials |
| NCT00003902 | Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement | completed | Phase 1 / Phase 2 | 110 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00031876 | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 34 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00251472 | A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer | completed | Phase 2 | 72 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00768859 | Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study(TRAIN) | completed | Phase 2 | 111 | The Netherlands Cancer InstituteOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00083278 | Study of MDX-010 in Stage IV Breast Cancer | completed | Phase 2 | 33 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00467012 | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer | completed | Phase 2 | 122 | Chugai PharmaceuticalINDUSTRY | 1 | Apr 26, 2012 | clinicaltrials |
| NCT00816244 | Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | completed | Phase 2 | 50 | Lund University HospitalOTHER | 1 | Apr 13, 2012 | clinicaltrials |
| NCT01208480 | Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer | completed | Phase 2 | 45 | Severance HospitalOTHER | 1 | Apr 10, 2012 | clinicaltrials |
| NCT00265655 | Satraplatin for Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01048528 | Health SMART (Stress Management and Relaxation Training) | completed | Phase 2 | 33 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 27, 2012 | clinicaltrials |
| NCT01089049 | Effect of a Natural Health Product on Urinary Estrogen Metabolites | completed | Phase 1 / Phase 2 | 98 | Nutrasource Pharmaceutical and Nutraceutical Services, Inc.NETWORK | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019812 | Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2 | completed | Phase 2 | 55 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00149214 | Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens | completed | Phase 2 | 257 | Eli Lilly and CompanyINDUSTRY | 4 | Mar 21, 2012 | clinicaltrials |
| NCT00454532 | A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 27 | BionovoINDUSTRY | 0 | Mar 16, 2012 | clinicaltrials |
| NCT00002585 | Pyrazoloacridine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 20 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00064311 | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00301899 | Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab | completed | Phase 2 | 37 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00233974 | Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery | completed | Phase 2 | 15 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT00003392 | High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | completed | Phase 2 | 61 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 22, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Aug 16, 2012source: clinicaltrials